Re: [PPML] FDA approves abiraterone acetate for mCRPC

[Guest guest]

Here is the press release:

http://www.prnewswire.com/news-releases/fda-approves-zytiga-for-late-stage-prostate-cancer-120881469.html

It appears the name going forward is 'Zytiga'

 

The FDA has today approved abioraterone acetate for the treatment of mCRPC in men who have previously been treated with docetaxel-based chemotherapy. We shall have more info on http://prostatecancerinfolink.net shortly.

=====================================================For info on managing your subscription: http://ppml-info.org/welcome.htmlNeed more help? Send email to: prostate-request@...

-- Emersonwww.flhw.orgEvery 2.25 minutes a man is diagnosed with prostate cancer.

Every 16.5 minutes a man dies from the disease.